Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Entourage Health Corp ETRGF


Primary Symbol: V.ENTG

Healthcare
Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:ENTG)

Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

GlobeNewswire 13 hours ago

Entourage Health to Report Fiscal Year 2023 Financial Results

GlobeNewswire 6 days ago

Entourage Health Provides Corporate Update

GlobeNewswire December 5, 2023

Entourage Health Reports Third Quarter 2023 Financial Results and Posts $12.2 Million in Total Revenue

GlobeNewswire November 28, 2023

Entourage Health to Host Third Quarter 2023 Financial Results Call on November 28

GlobeNewswire November 8, 2023

Entourage Health Announces Amendment to Key Supply Agreement 

GlobeNewswire September 15, 2023

Entourage Health Reports Second Quarter 2023 Financial Results

GlobeNewswire August 30, 2023

Entourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis 

GlobeNewswire August 24, 2023

Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30

GlobeNewswire August 9, 2023
View More News ››

Opinion & Analysis (TSXV:ENTG)

DOJA / HIKU Brands interview - Stockhouse Road Trip Ep.1

Stockhouse Editorial February 16, 2018
View More Opinion ››

Bullboard Posts (TSXV:ENTG)

ENTG Has Achieved Profitability for 2023!

Profitability was achieved by implementing efficiencies and other carefully calibrated dynamics as outlined in impressive detail within...
Wrywisdom - 8 hours ago

Financials Out After Bell on Monday...A Stellar Opportunity!

Fundamentals still do matter in the midst of massive market irrationality, ignorance and manipulation. Absurd that ENTG ever got to this...
Wrywisdom - 4 days ago

RE:An Opportune Time to Jump In Big or Add to ENTG Position

Adding a little levity to the situation. Hey Wry, don't thing they are muffling the excitement I believe they have choked it to death...
Nicksonsnowboar - 12 days ago

RE:An Opportune Time to Jump In Big or Add to ENTG Position

Well another month has gone by. Their earnings and cash flow are negative. Their debt to capital  is a negative 600%+. The Canadian ...
Nicksonsnowboar - February 27, 2024

RE:Trading at a penny...

No interest usually is related to no sales , no revenue stream ,no new markets etc. Have they ever reported anything between quarters...
Nicksonsnowboar - January 17, 2024

Trading at a penny...

..and today's volume was less than 4000 shares. The transaction fee was more than the cost of the shares!!   That said, all pot...
prested - January 9, 2024
View more Bullboard ››

NurExone Biologic Inc

NurExone Biologic Inc

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ...
View More »